In situ hybridization (ISH) has localized decorin in areas of microvascular proliferation within gliomas and may be a therapeutic target in anti-angiogenic therapy (Patel et al., 2020) or approaches targeting TGF-β activity in tumors (Birch et al., 2020). Here, TGFB1 is linked to central nervous system cancer.